Endothelial function as a functional expression of cardiovascular risk factors
- PMID: 20550469
- PMCID: PMC2911781
- DOI: 10.2217/bmm.10.61
Endothelial function as a functional expression of cardiovascular risk factors
Abstract
Traditional cardiovascular risk (CV) factors based on the Framingham study have been used to estimate the risk of CV events and determine target cholesterol levels for primary prevention. Recently published systematic reviews have, however, demonstrated that the Framingham risk score is limited in certain cohorts and requires adjustment. Indeed, traditional CV risk factors fail to predict the development of coronary heart disease in 25-50% of cases. This underscores the complex interplay between traditional CV risk factors, genetic predisposition and other atheroprotective factors present in individuals of different populations in predicting CV events. Endothelial dysfunction, a functional expression of the inherent atherosclerotic risk representing an integrated index of both the overall CV risk-factor burden and the sum of all vasculoprotective factors in an individual, may serve as the missing link between CV risk factors and atherosclerotic disease. Endothelial function measurements may aid in future prediction of CV events and help identify high-risk patients for targeted therapy as well as provide a primary therapeutic end point for clinical follow-up of these patients. Recently introduced reactive hyperemia peripheral arterial tonometry is emerging as a promising tool in endothelial function measurement and CV risk stratification.
Figures



Similar articles
-
Assessment of peripheral endothelial function predicts future risk of solid-tumor cancer.Eur J Prev Cardiol. 2020 Apr;27(6):608-618. doi: 10.1177/2047487319884246. Epub 2019 Oct 31. Eur J Prev Cardiol. 2020. PMID: 31668110
-
Peripheral endothelial function and cardiovascular events in high-risk patients.J Am Heart Assoc. 2013 Nov 25;2(6):e000426. doi: 10.1161/JAHA.113.000426. J Am Heart Assoc. 2013. PMID: 24275629 Free PMC article.
-
Endothelial dysfunction: a marker of atherosclerotic risk.Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):168-75. doi: 10.1161/01.atv.0000051384.43104.fc. Arterioscler Thromb Vasc Biol. 2003. PMID: 12588755 Review.
-
Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function.Mayo Clin Proc. 2012 Oct;87(10):968-75. doi: 10.1016/j.mayocp.2012.07.004. Epub 2012 Sep 12. Mayo Clin Proc. 2012. PMID: 22980166 Free PMC article.
-
Secondary prevention strategy of cardiovascular disease using endothelial function testing.Circ J. 2015;79(4):685-94. doi: 10.1253/circj.CJ-15-0068. Epub 2015 Feb 27. Circ J. 2015. PMID: 25740088 Review.
Cited by
-
Peripheral Arterial Tonometry (EndoPAT)-measured Endothelial Dysfunction in Migraine with Aura children.Acta Biomed. 2022 Mar 21;92(S4):e2021345. doi: 10.23750/abm.v92iS4.12674. Acta Biomed. 2022. PMID: 35441605 Free PMC article.
-
Coronary endothelial function testing may improve long-term quality of life in subjects with microvascular coronary endothelial dysfunction.Open Heart. 2019 Feb 2;6(1):e000870. doi: 10.1136/openhrt-2018-000870. eCollection 2019. Open Heart. 2019. PMID: 30815267 Free PMC article.
-
Effect of non-alcoholic beer, diet and exercise on endothelial function, nutrition and quality of life in patients with cirrhosis.World J Hepatol. 2020 Dec 27;12(12):1299-1313. doi: 10.4254/wjh.v12.i12.1299. World J Hepatol. 2020. PMID: 33442456 Free PMC article. Clinical Trial.
-
Sympathetic regulation of vascular function in health and disease.Front Physiol. 2012 Jul 24;3:284. doi: 10.3389/fphys.2012.00284. eCollection 2012. Front Physiol. 2012. PMID: 22934037 Free PMC article.
-
Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice.Cardiovasc Diabetol. 2011 Jul 14;10:62. doi: 10.1186/1475-2840-10-62. Cardiovasc Diabetol. 2011. PMID: 21756303 Free PMC article.
References
-
- Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355(25):2631–2639. - PubMed
-
- Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23(2):168–175. - PubMed
-
- Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288(5789):373–376. - PubMed
-
- Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332(6163):411–415. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical